Your browser doesn't support javascript.
loading
Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes.
Sunagawa, Yoichi; Funamoto, Masafumi; Sono, Shogo; Shimizu, Kana; Shimizu, Satoshi; Genpei, Mai; Miyazaki, Yusuke; Katanasaka, Yasufumi; Morimoto, Eriko; Ueno, Morio; Komiyama, Maki; Kakeya, Hideaki; Wada, Hiromichi; Hasegawa, Koji; Morimoto, Tatsuya.
Afiliación
  • Sunagawa Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan; Shizuoka General Hospital, Shizuoka 420-8527, Japan; Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555, Japan.
  • Funamoto M; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Sono S; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Shimizu K; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Shimizu S; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Genpei M; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Miyazaki Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
  • Katanasaka Y; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan; Shizuoka General Hospital, Shizuoka 420-8527, Japan; Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555, Japan.
  • Morimoto E; Shizuoka General Hospital, Shizuoka 420-8527, Japan.
  • Ueno M; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 612-8566, Japan.
  • Komiyama M; Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555, Japan.
  • Kakeya H; Department of System Chemotherapy and Molecular Sciences, Division of Bioinformatics and Chemical Genomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
  • Wada H; Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555, Japan.
  • Hasegawa K; Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555, Japan.
  • Morimoto T; Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan; Shizuoka General Hospital, Shizuoka 420-8527, Japan; Clinical Research Institute, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555, Japan. Electronic address: mori
J Pharmacol Sci ; 136(4): 212-217, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29602708
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Curcumina / Miocitos Cardíacos / Factores de Transcripción p300-CBP Límite: Animals / Humans Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Curcumina / Miocitos Cardíacos / Factores de Transcripción p300-CBP Límite: Animals / Humans Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón